Miracle Mile Advisors’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.3M Sell
395,751
-1,133
-0.3% -$44.8K 0.19% 99
2026
Q1
$14.1M Buy
396,884
+5,354
+1% +$200K 0.19% 98
2025
Q4
$15M Buy
391,530
+9,190
+2% +$352K 0.21% 92
2025
Q3
$14.4M Buy
382,340
+24,063
+7% +$880K 0.22% 90
2025
Q2
$12.6M Buy
358,277
+38,503
+12% +$1.26M 0.21% 83
2025
Q1
$10.3M Buy
319,774
+58,330
+22% +$1.96M 0.21% 80
2024
Q4
$8.7M Buy
261,444
+34,982
+15% +$1.18M 0.18% 89
2024
Q3
$7.53M Buy
226,462
+66,500
+42% +$2.13M 0.17% 84
2024
Q2
$5.02M Buy
159,962
+84,157
+111% +$2.55M 0.12% 108
2024
Q1
$2.29M Buy
+75,805
New +$2.19M 0.06% 170

Other funds holding TCAF

Miracle Mile Advisors's TCAF Position: Q2 2026 in Review

Miracle Mile Advisors reduced its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 0.29% in Q2 2026, selling an estimated $44.8K and leaving 395,751 shares worth $16.3M. The position accounts for 0.19% of the portfolio, ranked #99.

Miracle Mile Advisors first reported a position in TCAF in Q1 2024 and has held it in 10 quarters since. 358 funds tracked by Wall St. Rank hold TCAF as of Q2 2026.

  • Miracle Mile Advisors held 395,751 shares of T. Rowe Price Capital Appreciation Equity ETF worth $16.3M as of Q2 2026.
  • Miracle Mile Advisors sold 1,133 T. Rowe Price Capital Appreciation Equity ETF shares in Q2 2026, an estimated $44.8K.
  • T. Rowe Price Capital Appreciation Equity ETF made up 0.19% of Miracle Mile Advisors's portfolio in Q2 2026, its #99 holding.
  • Miracle Mile Advisors first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q1 2024 and has held it in 10 quarters since.
  • 358 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.